Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

布洛芬注射用浓溶液 - NMPA Drug Approval Details

Approvals/NMPA/Ibuprofen Concentrated Solution for Injection

Approved

化学药品

Ibuprofen Concentrated Solution for Injection

成都苑东生物制药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Mar 9, 2023
Approval ID: 7ucbXKpcVer
Company: 成都苑东生物制药股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7ucbXKpcVer
Approval Number: 国药准字H20183344
Generic Name: 布洛芬注射用浓溶液
Generic Name En: Ibuprofen Concentrated Solution for Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 4ml:0.4g
Reg Date: 2023-03-09
Company Name: 成都苑东生物制药股份有限公司
Company Address: 成都高新区西源大道8号
Production Company Name: 成都苑东生物制药股份有限公司;成都市海通药业有限公司
Production Company Address: 成都高新区西源大道8号；成都市海峡两岸科技产业开发园柳台大道222号
Company Detail Path: /organization/chengdu-easton-biopharmaceuticals-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 9, 2023

Approval ID

7ucbXKpcVer

Type

化学药品

Back to NMPA Approvals